News

Deal Announcements

Gliknik Adds $5 Million Venture Capital Funding

Tuesday, April 30, 2013 5:34:00 AM PDT | VentureDeal
   Baltimore, MD  --  Biotechnology company Gliknik has added $5 million in venture capital investment, according to an SEC regulatory filing.

Gliknik is developing treatments for patients with cancer and autoimmune diseases by modulating the immune system.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Gliknik is still seeking $5.2 million in financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1